Valneva SE ADR (VALN)

  • Get an in-depth profile of Valneva SE ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.
14.11 -0.09 (-0.63%)
Closed USD Disclaimer

Valneva SE ADR Company Profile

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
700
Equity Type
ADR
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is headquartered in Saint-Herblain, France.
Contact Information
Address
Saint-Herblain,44800 France
Phone
33 2 28 07 37 10
Fax
-
Web
https://valneva.com
Top Executives
Name
Age
Since
Title
Frederic Grimaud 56 2002 Chairman of Supervisory Board
Anne-Marie Graffin 60 2013 Independent Member of Supervisory Board
James R. Sulat 71 2013 Independent Vice Chairman of the Supervisory Board
Ralf Clemens 68 2016 Chair of Scientific Advisory Board
Sharon Elizabeth Tetlow 62 2020 Independent Supervisory Board Member
Alexander Von Gabain 72 2013 Member of Scientific Advisory Board
George R. Siber 77 2019 Member of Scientific Advisory Board
Mailys Ferrere 60 2022 Member of Supervisory Board
Johanna Willemina Pattenier 62 2020 Independent Supervisory Board Member
James Edward Connolly 0 2022 Member of Supervisory Board
Norman W. Baylor 0 2019 Member of Scientific Advisory Board
Thomas Decker 0 2022 Member of Scientific Advisory Board
Michael Pfleiderer 0 2022 Member of Scientific Advisory Board
Anna Durbin 0 2019 Member of Scientific Advisory Board

Customize

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.